Healthy Volunteers, Renal Impairment and End Stage Kidney Disease research hub

A Single Dose, Non-randomised, Open-label, Parallel Group Study to Assess the Pharmacokinetics, Safety, and Tolerability of AZD4144 in Participants with Severe Renal Impairment, End-stage Kidney Disease, and in Healthy Participants

This study looks at a new medicine called AZD4144 in people with severe kidney problems, those on dialysis, and healthy volunteers. It checks how the body handles the medicine, if it's safe, and if it causes any side effects. It's an early-stage study.